Mode
Text Size
Log in / Sign up
N/A N=82 Other

Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk

Breastfeeding

Enrolled (actual)
82
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Baseline Sucralose Concentration in Breast Milk — 0.19 ng/ml

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Diet soda (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
George Washington University
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Baseline Sucralose Concentration in Breast Milk
0.19
PRIMARY
1-hour Sucralose Concentration in Breast Milk
0.48
PRIMARY
2-hour Sucralose Concentrations in Breast Milk
1.67
PRIMARY
3-hour Sucralose Concentrations in Breast Milk
3.23
PRIMARY
4-hour Sucralose Concentrations in Breast Milk
4.76
PRIMARY
6-hour Sucralose Concentrations in Breast Milk
6.61
PRIMARY
8-hour Sucralose Concentrations in Breast Milk
6.74
PRIMARY
12-hour Sucralose Concentrations in Breast Milk
5.18
PRIMARY
24-hour Sucralose Concentrations in Breast Milk
2.24
PRIMARY
Baseline Acesulfame-potassium Concentrations in Breast Milk
18.11
PRIMARY
1-hour Acesulfame-potassium Concentrations in Breast Milk
115.27
PRIMARY
2-hour Acesulfame-potassium Concentrations in Breast Milk
294.22
PRIMARY
3-hour Acesulfame-potassium Concentrations in Breast Milk
380.65
PRIMARY
4-hour Acesulfame-potassium Concentrations in Breast Milk
405.75
PRIMARY
6-hour Acesulfame-potassium Concentrations in Breast Milk
323.14
PRIMARY
8-hour Acesulfame-potassium Concentrations in Breast Milk
205.91
PRIMARY
12-hour Acesulfame-potassium Concentrations in Breast Milk
81.01
PRIMARY
24-hour Acesulfame-potassium Concentrations in Breast Milk
28.17
PRIMARY
Baseline Sucralose Concentration in Maternal Plasma
0.64
PRIMARY
30-min Sucralose Concentration in Maternal Plasma
38.03
PRIMARY
1 Hour Sucralose Concentration in Maternal Plasma
80.25
PRIMARY
1.5 Hour Sucralose Concentration in Maternal Plasma
90.45
PRIMARY
2 Hour Sucralose Concentration in Maternal Plasma
90.59
PRIMARY
3 Hour Sucralose Concentration in Maternal Plasma
75.85
PRIMARY
4 Hour Sucralose Concentration in Maternal Plasma
57.72
PRIMARY
6 Hour Sucralose Concentration in Maternal Plasma
31.28
PRIMARY
8 Hour Sucralose Concentration in Maternal Plasma
18.31
PRIMARY
12 Hour Sucralose Concentration in Maternal Plasma
8.31
PRIMARY
24 Hour Sucralose Concentration in Maternal Plasma
5.91
PRIMARY
48 Hour Sucralose Concentration in Maternal Plasma
3.61
PRIMARY
72 Hour Sucralose Concentration in Maternal Plasma
2.77
PRIMARY
Baseline Acesulfame-potassium Concentrations in Maternal Plasma
3.93
PRIMARY
30 Min Acesulfame-potassium Concentrations in Maternal Plasma
192.2
PRIMARY
1 Hour Acesulfame-potassium Concentrations in Maternal Plasma
308.98
PRIMARY
1.5 Hour Acesulfame-potassium Concentrations in Maternal Plasma
348.84
PRIMARY
2 Hour Acesulfame-potassium Concentrations in Maternal Plasma
355.69
PRIMARY
3 Hour Acesulfame-potassium Concentrations in Maternal Plasma
290.56
PRIMARY
4 Hour Acesulfame-potassium Concentrations in Maternal Plasma
203.23
PRIMARY
6 Hour Acesulfame-potassium Concentrations in Maternal Plasma
106.05
PRIMARY
8 Hour Acesulfame-potassium Concentrations in Maternal Plasma
58.09
PRIMARY
12 Hour Acesulfame-potassium Concentrations in Maternal Plasma
20.91
PRIMARY
24 Hour Acesulfame-potassium Concentrations in Maternal Plasma
5.26
PRIMARY
48 Hour Acesulfame-potassium Concentrations in Maternal Plasma
8.44
PRIMARY
72 Hour Acesulfame-potassium Concentrations in Maternal Plasma
8.16
PRIMARY
Sucralose Concentrations in Infant Plasma
5.0
PRIMARY
Acesulfame-potassium Concentrations in Infant Plasma
9.2

Summary

This project aims to measure the widely consumed low-calorie sweeteners (LCS) sucralose and acesulfame-potassium, in maternal breast milk and plasma at pre-specified timepoints over 72 hours and in a single sample of infants' plasma. Sucralose and acesulfame-potassium concentrations will be measured using liquid chromatography-mass spectrometry (LC-MS). The data generated will inform the design of larger, longer-term, prospective studies needed to investigate clinically-relevant consequences of early life LCS exposure in humans.

Eligibility Criteria

Inclusion Criteria

  • mother gave birth within the past 6 months
  • mother ≥18 years of age
  • exclusively breastfeeding
  • reports consumption of diet, low-calorie sweetener-containing beverages ≥ 1 time per week.
  • infants' corrected age >= 4 weeks

Exclusion Criteria

  • known allergy or contraindication to sucralose or acesulfame-potassium (infant or mother)
  • active nutritional disorder known to cause malabsorption
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05379270). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search